메뉴 건너뛰기




Volumn 14, Issue 12, 2004, Pages 1097-1102

Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD3 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; IODINE 123; LAMIVUDINE; PROPRANOLOL; RECOMBINANT INTERLEUKIN 2; SAQUINAVIR; STAVUDINE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

EID: 11344260900     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.1097     Document Type: Article
Times cited : (24)

References (44)
  • 4
    • 0027166292 scopus 로고
    • False-positive human immunodeficiency virus testing in patients with lupus erythematosus
    • Barthel HR, Wallace DJ 1993 False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin Arthritis Rheum 23:1-7.
    • (1993) Semin Arthritis Rheum , vol.23 , pp. 1-7
    • Barthel, H.R.1    Wallace, D.J.2
  • 10
    • 0034530915 scopus 로고    scopus 로고
    • Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients
    • Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, Kazatchkine MD, Gilquin J, Viara JP 2000 Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 85:4254-4257.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 4254-4257
    • Jubault, V.1    Penfornis, A.2    Schillo, F.3    Hoen, B.4    Izembart, M.5    Timsit, J.6    Kazatchkine, M.D.7    Gilquin, J.8    Viara, J.P.9
  • 11
    • 0025750149 scopus 로고
    • Thyroid function abnormalities associated with the chronic out-patient administration of recombinant interleukin-2 and recombinant interferon-alpha
    • Jacobs EL, Clare-Salzler MJ, Chopra IJ, Figlin RA 1991 Thyroid function abnormalities associated with the chronic out-patient administration of recombinant interleukin-2 and recombinant interferon-alpha. J Immunother 10:448-455.
    • (1991) J Immunother , vol.10 , pp. 448-455
    • Jacobs, E.L.1    Clare-Salzler, M.J.2    Chopra, I.J.3    Figlin, R.A.4
  • 15
    • 0036209488 scopus 로고    scopus 로고
    • The evaluation of subcutaneous Proleukin® (interleukin-2) in a randomized international trial: Rationale, design, and methods of ESPRIT
    • Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD; ESPRIT Study Group 2002 The evaluation of subcutaneous Proleukin® (interleukin-2) in a randomized international trial: Rationale, design, and methods of ESPRIT. Control Clin Trials 23:198-220.
    • (2002) Control Clin Trials , vol.23 , pp. 198-220
    • Emery, S.1    Abrams, D.I.2    Cooper, D.A.3    Darbyshire, J.H.4    Lane, H.C.5    Lundgren, J.D.6    Neaton, J.D.7
  • 17
    • 0030175368 scopus 로고    scopus 로고
    • Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat
    • Zipris D 1996 Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat. J Autoimmun 9:315-319.
    • (1996) J Autoimmun , vol.9 , pp. 315-319
    • Zipris, D.1
  • 18
    • 0036514975 scopus 로고    scopus 로고
    • Autoimmune thyroid disease: New models of cell death in autoimmunity
    • Stassi G, De Maria R 2002 Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev Immunol 2:195-204.
    • (2002) Nat Rev Immunol , vol.2 , pp. 195-204
    • Stassi, G.1    De Maria, R.2
  • 21
    • 0029923832 scopus 로고    scopus 로고
    • Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR)
    • Heuer M, Aust G, Ode-Hakim S, Scherbaum WA 1996 Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6:97-106.
    • (1996) Thyroid , vol.6 , pp. 97-106
    • Heuer, M.1    Aust, G.2    Ode-Hakim, S.3    Scherbaum, W.A.4
  • 22
    • 0033179165 scopus 로고    scopus 로고
    • The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals
    • Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, Trinchieri G 1999 The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 94:1003-1011.
    • (1999) Blood , vol.94 , pp. 1003-1011
    • Marshall, J.D.1    Chehimi, J.2    Gri, G.3    Kostman, J.R.4    Montaner, L.J.5    Trinchieri, G.6
  • 28
    • 0033730064 scopus 로고    scopus 로고
    • Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection
    • Diri E, Lipsky PE, Berggren RE 2000 Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 27:2711-2714.
    • (2000) J Rheumatol , vol.27 , pp. 2711-2714
    • Diri, E.1    Lipsky, P.E.2    Berggren, R.E.3
  • 29
    • 0035808515 scopus 로고    scopus 로고
    • Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy
    • Sereti I, Sarlis NJ, Arioglu E, Turner ML, Mican JM 2001 Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. AIDS 15:138-140.
    • (2001) AIDS , vol.15 , pp. 138-140
    • Sereti, I.1    Sarlis, N.J.2    Arioglu, E.3    Turner, M.L.4    Mican, J.M.5
  • 30
    • 0032512301 scopus 로고    scopus 로고
    • Delayed occurrence of Graves' disease after immune restoration with HAART (highly active antiretroviral therapy)
    • Gilquin J, Viard JP, Jubault V, Sert C, Kazatchkine MD 1998 Delayed occurrence of Graves' disease after immune restoration with HAART (highly active antiretroviral therapy). Lancet 352:1907-1908.
    • (1998) Lancet , vol.352 , pp. 1907-1908
    • Gilquin, J.1    Viard, J.P.2    Jubault, V.3    Sert, C.4    Kazatchkine, M.D.5
  • 31
    • 0037269502 scopus 로고    scopus 로고
    • Autoimmune thyroid disease: Propagation and progression
    • Weetman AP 2003 Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol 148:1-9.
    • (2003) Eur J Endocrinol , vol.148 , pp. 1-9
    • Weetman, A.P.1
  • 33
    • 0033510689 scopus 로고    scopus 로고
    • Peripheral blood and intrathyroidal T cell clones from patients with thyroid autoimmune diseases
    • Massart C, Caroff G, Maugendre D, Genetet N, Gibassier J 1999 Peripheral blood and intrathyroidal T cell clones from patients with thyroid autoimmune diseases. Autoimmunity 31:163-174.
    • (1999) Autoimmunity , vol.31 , pp. 163-174
    • Massart, C.1    Caroff, G.2    Maugendre, D.3    Genetet, N.4    Gibassier, J.5
  • 36
    • 0031924728 scopus 로고    scopus 로고
    • Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen
    • Deas JE, Liu LG, Thompson JJ, Sander JM, Soble SS, Garry RF, Gallaher WR 1998 Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin Diagn Lab Immunol 5:181-185.
    • (1998) Clin Diagn Lab Immunol , vol.5 , pp. 181-185
    • Deas, J.E.1    Liu, L.G.2    Thompson, J.J.3    Sander, J.M.4    Soble, S.S.5    Garry, R.F.6    Gallaher, W.R.7
  • 37
    • 0034843106 scopus 로고    scopus 로고
    • Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy
    • Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA 2001 Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 22:279-287.
    • (2001) J Clin Virol , vol.22 , pp. 279-287
    • Price, P.1    Mathiot, N.2    Krueger, R.3    Stone, S.4    Keane, N.M.5    French, M.A.6
  • 39
    • 0033304495 scopus 로고    scopus 로고
    • Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I
    • Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L, Ferrari E 1999 Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. J Clin Endocrinol Metab 84:3260-3267.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3260-3267
    • Solerte, S.B.1    Fioravanti, M.2    Vignati, G.3    Giustina, A.4    Cravello, L.5    Ferrari, E.6
  • 41
    • 0027403432 scopus 로고
    • The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness
    • Wisniewski TL, Hilton CW, Morse EV, Svec F 1993 The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305:79-83.
    • (1993) Am J Med Sci , vol.305 , pp. 79-83
    • Wisniewski, T.L.1    Hilton, C.W.2    Morse, E.V.3    Svec, F.4
  • 42
    • 3042608380 scopus 로고    scopus 로고
    • Perturbation of natural killer cell function and receptors during HIV infection
    • Eger KA, Unutmaz D 2004 Perturbation of natural killer cell function and receptors during HIV infection. Trends Microbiol 12:301-303.
    • (2004) Trends Microbiol , vol.12 , pp. 301-303
    • Eger, K.A.1    Unutmaz, D.2
  • 43
    • 0036282713 scopus 로고    scopus 로고
    • Over-the-counter sports supplements: What clinicians need to know
    • Kenkare ZN, Federman DG 2002 Over-the-counter sports supplements: What clinicians need to know. Compr Ther 28:148-154.
    • (2002) Compr Ther , vol.28 , pp. 148-154
    • Kenkare, Z.N.1    Federman, D.G.2
  • 44
    • 0037639719 scopus 로고    scopus 로고
    • Integrating IL-12 into therapeutic cancer vaccines
    • Gajewski TF 2002 Integrating IL-12 into therapeutic cancer vaccines. Cancer Chemother Biol Response Modif 20:343-349.
    • (2002) Cancer Chemother Biol Response Modif , vol.20 , pp. 343-349
    • Gajewski, T.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.